Your Cart

Your cart is empty

Continue shopping
Skip to main content


Acetyl-L-Carnitine -- Brain Superfuel!

Jan 23rd 2024

Acetyl-L-Carnitine -- Brain Superfuel!

Product Overview

Acetyl-L-carnitine maintains and improves brain function. It energizes and rejuvenates brain cells. It's been called "brain superfuel!"

It improves learning ability, reaction time, accuracy, mental performance, verbal fluency, attention, memory, and even your mood! It facilitates repair of brain cells damaged by poor nutrition, stress, toxins and trauma. Many people report less confusion, brain fog, enhanced alertness and focus, and feeling mentally sharper within hours of taking it.

It slows the rate of deterioration in Alzheimer's disease and significantly improves mental functioning in those who suffer from this illness.

A host of scientific studies have shown that acetyl-l-carnitine prevents age-related cognitive decline through various mechanisms at dosages of 1-3 grams a day. A meta-analysis of 21 studies found a cumulative effect, suggesting that long-term use may provide the greatest benefit.

Complimentary Supplements

Because it's naturally found in the body, side effects are rare, however it can be energizing, so it's often best not to take it after 4 PM. Unlike most supplements, it should be taken away from food (one hour before a meal or two hours after). Adding 100-300 mg per day of CoQ10, 100-300 mg of phosphatidyl serine, and 250-500 mg of alpha lipoic acid would be very synergistic.

It's extremely important that an acetyl-L-carnitine product be very pure, and that its molecules be in the correct biological form required by the body. There should be no solvent residues or D-carnitine present. Doing this correctly requires care and knowledge. Studies show that the overwhelming majority of nutritional supplements don't meet these standards. Beyond Health supplies an acetyl-L-carnitine product that meets exacting standards for quality and effectiveness.

Francis, R. Protecting your brain with acetyl-L-carnitine. Beyond Health News, May-June 2006. p. 5.
Montgomery SA. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. International Clinical Psychopharmacology, March 2003;8(2):61-71.




Information contained in NewsClips articles should not be construed as personal medical advice or instruction. These statements have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure or prevent any disease.